Presentation by Kari Wong, Associate Director, Scientific Strategy, Metabolon, USA

Integrating Metabolomics into NASH Research and Development

Share this article:

Microbiome --Linked NASH biomarker

In this presentation Kari Wong focuses on Metabolon’s mass spectrometry-based technology. This allows for the identification of over 1000 small molecules in a single sample and is well suited to be integrated into other-omics data streams. By simultaneously surveying diverse metabolic pathways in a single sample, Metabolon’s global platform provides a holistic assessment of NAFLD/NASH complexity.